loadpatents
Patent applications and USPTO patent grants for Mir; Aamir.The latest application filed is for "programmable dna base editing by nme2cas9-deaminase fusion proteins".
Patent | Date |
---|---|
Programmable Dna Base Editing By Nme2cas9-deaminase Fusion Proteins App 20220290113 - Sontheimer; Erik J. ;   et al. | 2022-09-15 |
Dual Strand Nucleic Acid-guided Nickase Editing App 20220275377 - Chaikind; Brian ;   et al. | 2022-09-01 |
Cascade/dCas3 Complementation Assays for In Vivo Detection of Nucleic Acid-Guided Nuclease Edited Cells App 20220267747 - Mir; Aamir ;   et al. | 2022-08-25 |
Mad Nucleases App 20220213458 - Kim; Juhan ;   et al. | 2022-07-07 |
Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells Grant 11,359,187 - Mir , et al. June 14, 2 | 2022-06-14 |
Cascade/dCas3 Complementation Assays for In Vivo Detection of Nucleic Acid-Guided Nuclease Edited Cells App 20220177865 - Mir; Aamir ;   et al. | 2022-06-09 |
gRNA STABILIZATION IN NUCLEIC ACID-GUIDED NICKASE EDITING App 20220177957 - Mir; Aamir | 2022-06-09 |
Engineered enzymes Grant 11,345,903 - Mijts , et al. May 31, 2 | 2022-05-31 |
Mad nucleases Grant 11,332,742 - Kim , et al. May 17, 2 | 2022-05-17 |
Mad nucleases Grant 11,306,298 - Kim , et al. April 19, 2 | 2022-04-19 |
Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells Grant 11,286,471 - Mir , et al. March 29, 2 | 2022-03-29 |
Cascade/dCas3 Complementation Assays for In Vivo Detection of Nucleic Acid-Guided Nuclease Edited Cells App 20220073892 - Mir; Aamir ;   et al. | 2022-03-10 |
Novel Mad Nucleases App 20220049233 - Mijts; Benjamin ;   et al. | 2022-02-17 |
Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells Grant 11,198,857 - Mir , et al. December 14, 2 | 2021-12-14 |
Mad nucleases Grant 11,193,115 - Mijts , et al. December 7, 2 | 2021-12-07 |
Modified Guide Rnas For Crispr Genome Editing App 20210363518 - SONTHEIMER; Erik Joseph ;   et al. | 2021-11-25 |
Cascade/dCas3 Complementation Assays for In Vivo Detection of Nucleic Acid-Guided Nuclease Edited Cells App 20210355467 - Mir; Aamir ;   et al. | 2021-11-18 |
Mad nucleases Grant 11,174,471 - Mijts , et al. November 16, 2 | 2021-11-16 |
Compositions, Methods, Modules And Instruments For Automated Nucleic Acid-guided Nuclease Editing In Mammalian Cells Using Microcarriers App 20210332389 - Belgrader; Phillip ;   et al. | 2021-10-28 |
Novel Mad Nucleases App 20210324355 - Mijts; Benjamin ;   et al. | 2021-10-21 |
Novel Mad Nucleases App 20210301270 - Mijts; Benjamin ;   et al. | 2021-09-30 |
Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells Grant 11,104,890 - Mir , et al. August 31, 2 | 2021-08-31 |
MAD nucleases Grant 11,085,030 - Mijts , et al. August 10, 2 | 2021-08-10 |
Cell Populations With Rationally Designed Edits App 20210214671 - Mir; Aamir ;   et al. | 2021-07-15 |
Automated Multi-module Cell Processing Methods, Instruments, And Systems App 20210214672 - Mir; Aamir ;   et al. | 2021-07-15 |
MAD nucleases Grant 11,053,485 - Mijts , et al. July 6, 2 | 2021-07-06 |
Novel Mad Nucleases App 20210198641 - Mijts; Benjamin ;   et al. | 2021-07-01 |
Novel Mad Nucleases App 20210171923 - Mijts; Benjamin ;   et al. | 2021-06-10 |
Engineered Enzymes App 20210155912 - Mijts; Benjamin ;   et al. | 2021-05-27 |
Cascade/dCas3 complementation assays for in vivo detection of nucleic acid-guided nuclease edited cells Grant 11,008,557 - Mir , et al. May 18, 2 | 2021-05-18 |
Mad nucleases Grant 10,883,095 - Mijts , et al. January 5, 2 | 2021-01-05 |
Engineered enzymes Grant 10,876,102 - Mijts , et al. December 29, 2 | 2020-12-29 |
Nucleic acid-guided nucleases Grant 10,870,841 - Mijts , et al. December 22, 2 | 2020-12-22 |
Engineered Enzymes App 20200354703 - Mijts; Benjamin ;   et al. | 2020-11-12 |
Nucleic acid-guided nucleases Grant 10,767,169 - Kim , et al. Sep | 2020-09-08 |
Nucleic acid-guided nucleases Grant 10,745,678 - Kim , et al. A | 2020-08-18 |
Nucleic acid-guided nucleases Grant 10,724,021 - Kim , et al. | 2020-07-28 |
Nucleic acid-guided nucleases Grant 10,704,033 - Kim , et al. | 2020-07-07 |
Automated multi-module cell processing methods, instruments, and systems Grant 10,689,669 - Feldman , et al. | 2020-06-23 |
Engineered Enzymes App 20200181592 - Mijts; Benjamin ;   et al. | 2020-06-11 |
Engineered enzymes Grant 10,655,114 - Mijts , et al. | 2020-05-19 |
Engineered enzymes Grant 10,640,754 - Mijts , et al. | 2020-05-05 |
Engineered Enzymes App 20200123517 - Mijts; Benjamin ;   et al. | 2020-04-23 |
Engineered enzymes Grant 10,604,746 - Mijts , et al. | 2020-03-31 |
Compositions And Methods For Improved Gene Editing App 20190345479 - Mello; Craig Cameron ;   et al. | 2019-11-14 |
Targeted CRISPR Delivery Platforms App 20190338308 - Sontheimer; Erik J. ;   et al. | 2019-11-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.